<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8" />
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=1.0, maximum-scale=1.0, minimum-scale=1.0, user-scalable=no" />
        <title>References</title>

        <link href="../jquery-mobile/jquery.mobile.theme-1.2.0.min.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.swatch.f.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.swatch.l.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/custom_arrow.css" rel="stylesheet" type="text/css"/>
        <link href="../jquery-mobile/jquery.mobile.structure-1.2.0.min.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/full.css" rel="stylesheet" type="text/css"/>
        <link href="../assets/css/recreated_tables.css" rel="stylesheet" type="text/css"/>
        <script src="../jquery-mobile/jquery-1.8.2.min.js" type="text/javascript"></script>
        <script src="../jquery-customization.js" type="text/javascript"></script>
        <script src="../jquery-mobile/jquery.mobile-1.2.0.min.js" type="text/javascript"></script>
        <script src="../cordova-2.2.0.js" type="text/javascript" charset="utf-8"></script>
        <script src="../assets/js/metrics.js" type="text/javascript" charset="utf-8"></script>

    </head>
    <body>

        <!-- Start of page -->
        <div data-role="page" id="heading_page_2" data-theme="d">
            <div data-role="header" data-id="references-header" data-theme="l" data-position="fixed">
                <a href="lv-0.html" data-role="button" data-iconshadow="false" data-corners="false" data-theme="reset" data-transition="fade" class="back_button" role="button" aria-label="back"></a>
                <h1>References</h1>
	            <a href="../menu.html"  rel="external" data-role="button" data-theme="reset" data-transition="fade" data-iconshadow="false" data-corners="false" class="menu_button ui-btn-right" role="button" aria-label="main menu"></a>
            </div>  <!-- end of header div -->

            <div data-role="content">
            <div id=references_breadcrumbs>
            
                    <a href="lv-0.html" >References</a><span class="carrot"> > </span>References 51-100
            </div>   <!-- end of references listview breadcrumbs -->
            </br><h1 id="sigil_toc_id_1">
 References 51-100
</h1>
<p>
 51. Auvert B, Sobngwi-Tambekou J, Cutler E, et al. Effect of male circumcision&nbsp;on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa. J Infect Dis 2009;199:14&ndash;9.
</p>
<p>
 52. Sobngwi-Tambekou J, Taljaard D, Lissouba P, et al. Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis 2009;199:958&ndash;64.
</p>
<p>
 53. Sobngwi-Tambekou J, Taljaard D, Nieuwoudt M, et al. Male circumcision&nbsp;and Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis: observations after a randomised controlled trial for HIV prevention. Sex Transm Infect 2009;85:116&ndash;20.
</p>
<p>
 54. Tobian AA, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009;360:1298&ndash;309.
</p>
<p>
 55. Millett GA, Flores SA, Marks G, et al. Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis. JAMA 2008;300:1674&ndash;84.
</p>
<p>
 56. UNAIDS, WHO. New data on male circumcision and HIV prevention: policy and programme implications: WHO/UNAIDS technical consultation&nbsp;male circumcision and HIV prevention&mdash;research implications for policy and programming. Geneva: Joint United Nations Programme on HIV/AIDS and World Health Organization; 2007.
</p>
<p>
 57. Smith DK, Taylor A, Kilmarx PH, et al. Male circumcision in the United States for the prevention of HIV infection and other adverse health outcomes: report from a CDC consultation. Public Health Rep 2010;125(Suppl 1):72&ndash;82.
</p>
<p>
 58. Cheng L, Gulmezoglu AM, Piaggio G, et al. Interventions for emergency contraception (update of 2004 document). Cochrane Database Syst Rev 2008;(2):CD001324.
</p>
<p>
 59. Myer L, Kuhn L, Stein ZA, et al. Intravaginal practices, bacterial vaginosis,&nbsp;and women&lsquo;s susceptibility to HIV infection: epidemiological evidence&nbsp;and biological mechanisms. Lancet Infect Dis 2005;5:786&ndash;94.
</p>
<p>
 60. Cohen MS, Gay C, Kashuba AD, et al. Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann Intern Med 2007;146:591&ndash;601.
</p>
<p>
 61. Peterson L, Taylor D, Roddy R, et al. Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials 2007;2:e27.
</p>
<p>
 62. Cohen MS, Kashuba AD. Antiretroviral therapy for prevention of HIV infection: new clues from an animal model. PLoS Med 2008;5:e30.
</p>
<p>
 63. Karim QA, Karim SS, Frohlich JA, et al; The CAPRISA 004 Trial Group. Available at Science express/
 <a href="http://www.sciencexpress.org" rel="external" target="_blank">
  www.sciencexpress.org
 </a>
 /19 July 2010/10.1126/science.1193748.
</p>
<p>
 64. Peterman TA, Tian LH, Metcalf CA, et al. High incidence of new sexually&nbsp;transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med 2006;145:564&ndash;72.
</p>
<p>
 65. Hogben M. Partner notification for sexually transmitted diseases. Clin Infect Dis 2007;44(Suppl 3):S160&ndash;74.
</p>
<p>
 66. Wilson TE, Hogben M, Malka ES, et al. A randomized controlled trial for reducing risks for sexually transmitted infections through enhanced patient-based partner notification. Am J Public Health 2009;99(Suppl 1):S104&ndash;10.
</p>
<p>
 67. Hodge JG, Jr., Pulver A, Hogben M, et al. Expedited partner therapy for sexually transmitted diseases: assessing the legal environment. Am J Public Health 2008;98:238&ndash;43.
</p>
<p>
 68. Golden MR, Whittington WL, Handsfield HH, et al. Effect of expedited&nbsp;treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 2005;352:676&ndash;85.
</p>
<p>
 69. Schillinger JA, Kissinger P, Calvet H, et al. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis 2003;30:49&ndash;56.
</p>
<p>
 70. Trelle S, Shang A, Nartey L, et al. Improved effectiveness of partner notification for patients with sexually transmitted infections: systematic review. BMJ 2007;334(7589):354.
</p>
<p>
 71. Kissinger P, Mohammed H, Richardson-Alston G, et al. Patient-delivered partner treatment for male urethritis: a randomized, controlled trial. Clin Infect Dis 2005;41:623&ndash;9.
</p>
<p>
 72. Kissinger P, Schmidt N, Mohammed H, et al. Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial. Sex Transm Dis 2006;33:445&ndash;50.
</p>
<p>
 73. Schwebke JR, Desmond RA. A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women. Sex Transm Dis 2010;37:392&ndash;6.
</p>
<p>
 74. Rothenberg R, Kimbrough L, Lewis-Hardy R, et al. Social network methods for endemic foci of syphilis: a pilot project. Sex Transm Dis 2000;27:12&ndash;8.
</p>
<p>
 75. Ogilvie G, Knowles L, Wong E, et al. Incorporating a social networking&nbsp;approach to enhance contact tracing in a heterosexual outbreak of syphilis. Sex Transm Inf 2005;81:124&ndash;7.
</p>
<p>
 76. Vest JR, Valadez AM, Hanner A, et al. Using e-mail to notify pseudonymous&nbsp;e-mail sexual partners. Sex Transm Dis 2007;34:840&ndash;5.
</p>
<p>
 77. CDC. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006;55(No. RR-14).
</p>
<p>
 78. CDC. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the US Department of Health and Human Services. MMWR 2005;54(No. RR-2).
</p>
<p>
 79. U.S. Preventive Services Task Force. Screening for syphilis infection in pregnancy: reaffirmation recommendation statement. Ann Intern Med 2009;150:705&ndash;9.
</p>
<p>
 80. U.S. Prevention Task Force. Screening for hepatitis B virus infection in pregnancy: reaffirmation recommendation statement. Ann Intern Med 2009;150:869&ndash;73.
</p>
<p>
 81. U.S. Preventive Services Task Force. Screening for chlamydial infection: recommendation statement. Ann Intern Med 2007;147:128&ndash;34.
</p>
<p>
 82. U.S. Preventive Services Task Force. Screening for gonorrhea: recommendation&nbsp;statement. Ann Fam Med 2005;3:263&ndash;7.
</p>
<p>
 83. Sadler L, Saftlas A, Wang W, et al. Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA 2004;291:2100&ndash;6.
</p>
<p>
 84. Serati M, Uccella S, Laterza RM, et al. Natural history of cervical intraepithelial neoplasia during pregnancy. Acta Obstet Gynecol Scand 2008;87:1296&ndash;1300.
</p>
<p>
 85. U.S. Preventive Services Task Force. Screening for bacterial vaginosis in pregnancy to prevent preterm delivery: recommendation statement. Ann Intern Med 2008;148:214&ndash;9.
</p>
<p>
 86. Chou R, Smits AK, Huffman LH, et al. Prenatal screening for HIV: A review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2005;143:38&ndash;54.
</p>
<p>
 87. American Academy of Pediatrics, American College of Obstetricians and Gynecologists. Guidelines for perinatal care, 6th ed. Washington, DC: American College of Obstetricians and Gynecologists; 2007.
</p>
<p>
 88. CDC. Rapid HIV antibody testing during labor and delivery for women of unknown HIV status: a practical guide and model protocol, 2004. Atlanta, GA: CDC, National Center for HIV, STD, and TB Prevention; 2004.
</p>
<p>
 89. American College of Obstetricians and Gynecologists. Viral hepatitis&nbsp;in pregnancy. ACOG Practice Bulletin No. 86. Obstet Gynecol 2007;110:941&ndash;56.
</p>
<p>
 90. Public Health Agency of Canada. Canadian guidelines on sexually transmitted infections. 2006 ed. Centre for Communicable Diseases and Infection Control; 2010. Available at
 <a href="http://www.phac-aspc.gc.ca/std-mts/sti-its/" rel="external" target="_blank">
  http://www.phac-aspc.gc.ca/std-mts/sti-its/
 </a>
 .
</p>
<p>
 91. Meyers D, Wolff T, Gregory K, et al. USPSTF recommendations for STI screening. Am Fam Physician 2008;77:819&ndash;24.
</p>
<p>
 92. Forhan SE, Gottlieb SL, Sternberg MR, et al. Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States. Pediatrics 2009;124:1505&ndash;12.
</p>
<p>
 93. CDC. Sexually Transmitted Disease Surveillance, 2008. Atlanta, GA: US Department of Health and Human Services, CDC; 2009.
</p>
<p>
 94. CDC. Male Chlamydia Screening Consultation, Atlanta, Georgia. March 28 &ndash; 29, 2006. Meeting Report, May 2007. Available at
 <a href="http://www.cdc.gov/std/chlamydia/ChlamydiaScreening-males.pdf" rel="external" target="_blank">
  http://www.cdc.gov/std/chlamydia/ChlamydiaScreening-males.pdf
 </a>
 .
</p>
<p>
 95. U.S. Preventive Services Task Force. Human immunodeficiency virus infection. Rockville, MD: Agency for Healthcare Research and Quality; 2007. Available at
 <a href="http://www.ahrq.gov/clinic/uspstf/uspshivi.htm" rel="external" target="_blank">
  http://www.ahrq.gov/clinic/uspstf/uspshivi.htm
 </a>
 .
</p>
<p>
 96. American College of Obstetricians and Gynecologists (ACOG). Cervical cytology screening. ACOG Practice Bulletin No. 109. Obstet Gynecol 2009;114:1409&ndash;20.
</p>
<p>
 97. U.S. Preventive Services Task Force. Screening for cervical cancer: recommendations. In press 2011.
</p>
<p>
 98. Sasieni P, Castanon A, Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ 2009;339:b2968.
</p>
<p>
 99. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. J Low Genit Tract Dis 2003;7:67&ndash;86.
</p>
<p>
 100. Chow JM, Joesoef MR, Kent C, et al. Responding to the burden of STD, HIV, and viral hepatitis in correctional populations through program collaboration and integration. Sex Transm Dis 2009;36(2 Suppl):S1&ndash;2.
</p>

            </div>
            <script type="text/javascript">

                $('div').live('pageshow', function (event, ui) {
                    document.addEventListener("deviceready", function(){
                        trackReferencesPageView("2");
                                                },true);
                });
            </script>
        </div>
        <!-- end of references heading page -->
    </body>
</html>

    